Evidence map›Paper›PMID 40327951›Full record

ReviewCurrent opinion in genetics & development2025

Molecular basis of cell fate plasticity - insights from the privileged cells.

Stephen Maxwell Scalf, Qiao Wu, Shangqin Guo

Abstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephen Maxwell ScalfDepartment of Cell Biology, Yale University, Yale Stem Cell Center, Yale University, United States.
Qiao WuDepartment of Cell Biology, Yale University, Yale Stem Cell Center, Yale University, United States.
Shangqin GuoDepartment of Cell Biology, Yale University, Yale Stem Cell Center, Yale University, United States. Electronic address: shangqin.guo@yale.edu.

Funding

Driving lymphoid potential in multipotent hematopoietic progenitors by linker histonesR56HL173442 · NHLBI · YALE UNIVERSITY · PI GUO, SHANGQIN · 2024 to 2024
$561k
NHLBI NIH HHS R56 HL173442
6 · The paper itself

Abstract

In the post-Yamanaka era, the rolling balls on Waddington's hilly landscape not only roll downward, but also go upward or sideways. This new-found mobility implies that the tantalizing somatic cell plasticity fueling regeneration, once only known to planarians and newts, might be sparking in the cells of mice and humans, if only we knew how to fully unlock it. The hope for ultimate regeneration was made even more tangible by the observations that partial reprogramming by the Yamanaka factors reverses many hallmarks of aging [76], even though the underlying mechanism remains unclear. We intend to revisit the milestones in the evolving understanding of cell fate plasticity and glean molecular insights from an unusual somatic cell state, the privileged cell state that reprograms in a manner defying the stochastic model. We synthesize our view of the molecular underpinning of cell fate plasticity, from which we speculate how to harness it for regeneration and rejuvenation. We propose that senescence, aging and malignancy represent distinct cell states with definable biochemical and biophysical parameters.

Indexed as

AgingCell DifferentiationCell LineageCell PlasticityCellular ReprogrammingRegenerationAnimalsCellular SenescenceHumansMice

Identifiers

PMID40327951
PMCPMC12277062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.